Advertisement

ASO Author Reflections: Colorectal Liver Metastases Early Progression After Chemotherapy: A Possible Contraindication to Surgery?

  • Guido Torzilli
  • Luca Viganò
ASO Author Reflections

Notes

Disclosures

The authors have no conflicts of interest to disclose.

References

  1. 1.
    Torzilli G, Procopio F, Botea F, et al. One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach. Surgery. 2009;146:60–71.CrossRefGoogle Scholar
  2. 2.
    Viganò L, Pedicini V, Comito T, et al. Aggressive and multidisciplinary local approach to iterative recurrences of colorectal liver metastases. World J Surg. 2018;42:2651.CrossRefGoogle Scholar
  3. 3.
    Viganò L, Capussotti L, Lapointe R, et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6025 patients. Ann Surg Oncol. 2014;21:1276–86.CrossRefGoogle Scholar
  4. 4.
    Gregoire E, Hoti E, Gorden DL, de la Serna S, Pascal G, Azoulay D. Utility or futility of prognostic scoring systems for colorectal liver metastases in an era of advanced multimodal therapy. Eur J Surg Oncol. 2010;36:568–74.CrossRefGoogle Scholar
  5. 5.
    Yamashita S, Chun YS, Kopetz SE, Vauthey JN. Biomarkers in colorectal liver metastases. Br J Surg. 2018;105:618–27.CrossRefGoogle Scholar
  6. 6.
    Viganò L, Darwish SS, Rimassa L, et al. Progression of colorectal liver metastases from the end of chemotherapy to resection: a new contraindication to surgery? Ann Surg Oncol. 2018;25(6):1676–85.CrossRefGoogle Scholar
  7. 7.
    Adam R, Imai K, Castro Benitez C, et al. Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases. Br J Surg. 2016;103(11):1521–9.CrossRefGoogle Scholar
  8. 8.
    Viganò L, Torzilli G, Cimino M, et al. Drop-out between the two liver resections of two-stage hepatectomy. Patient selection or loss of chance? Eur J Surg Oncol. 2016; 42:1385–93.CrossRefGoogle Scholar
  9. 9.
    Kambakamba P, Linecker M, Schneider M, et al. Impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on growth of colorectal liver metastases. Surgery. 2018;163:311–7.CrossRefGoogle Scholar
  10. 10.
    Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208–15.CrossRefGoogle Scholar
  11. 11.
    Viganò L, Capussotti L, Barroso E, et al. Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Ann Surg Oncol. 2012; 19:2786–96.CrossRefGoogle Scholar
  12. 12.
    Pitroda SP, Khodarev NN, Huang L, et al. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018;9(1):1793.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Division of Hepatobiliary and General Surgery, Department of SurgeryHumanitas University and Research HospitalRozzano, MilanItaly

Personalised recommendations